Pharma-Bio Industry Sees $6.8 Billion in Capital Investments From 214 Construction Projects Launched in First-Half 2012, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwire) -- 07/06/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the third quarter of 2012 begins, a look back over the past six months reveals that the has kicked off construction on nearly $7 billion worth of capital and MRO projects. The 214 projects are spread through North America and carry an average total investment value (TIV) of $32 million.
Other companies featured: (NYSE:ABT), (NYSE:STJ)
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
Joe Govreau
713-783-5147
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.07.2012 - 04:15 Uhr
Sprache: Deutsch
News-ID 1130621
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SUGAR LAND, TX
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 217 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharma-Bio Industry Sees $6.8 Billion in Capital Investments From 214 Construction Projects Launched in First-Half 2012, an Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
